Health care startups that raised Series A
Updated 23 Oct 2026
5,293
Companies
$70.3B
Last round total
100
Rows shown
Latest rounds
Most recent round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Estuary Biotherapeutics | Series A | $93.0M | 2026-10-16 | San Francisco | Biotech |
| 2 | Sunbound | Series A | $24.0M | 2026-10-15 | Washington | Artificial intelligence |
| 3 | Aibo Medical Robot | Series A | $14.1M | 2026-10-15 | Shenzhen | Hardware |
| 4 | Altay Therapeutics | Series A | $37.0M | 2026-10-14 | San Francisco | Biotech |
| 5 | Confido Health | Series A | $12.5M | 2026-10-14 | New York | Artificial intelligence |
| 6 | HydRegen | Series A | $8.0M | 2026-10-14 | Oxford | Biotech |
| 7 | Salary Hero | Series A | $7.6M | 2026-10-14 | Bangkok | Fintech |
| 8 | Allygen Biologics | Series A | $44.8M | 2026-10-13 | Beijing | Biotech |
| 9 | Readily | Series A | $11.0M | 2026-10-13 | San Francisco | Artificial intelligence |
| 10 | THE PHAGE | Series A | $3.6M | 2026-10-09 | Shibuya | Artificial intelligence |
| 11 | Vinci Pharmaceuticals | Series A | $8.0M | 2026-10-08 | Avon By The Sea | Health care |
| 12 | HealthLeap | Series A | $30.0M | 2026-10-07 | San Francisco | Artificial intelligence |
| 13 | HealthLeap | Series A | $30.0M | 2026-10-07 | San Francisco | Health care |
| 14 | Wally Health | Series A | $25.0M | 2026-10-07 | New York | Health care |
| 15 | Sunfox Technologies | Series A | $7.0M | 2026-10-07 | Dehra Dun | Hardware |
| 16 | GenMedicn Biopharma | Series A | 2026-10-07 | Nanjing | Biotech | |
| 17 | Vitalize | Series A | $31.0M | 2026-10-06 | San Francisco | Artificial intelligence |
| 18 | arboretum lifesciences | Series A | $30.0M | 2026-10-06 | Boston | Biotech |
| 19 | Sensible Biotechnologies | Series A | $27.0M | 2026-10-06 | Oxford | Artificial intelligence |
| 20 | Vocca | Series A | $20.0M | 2026-10-06 | Paris | Artificial intelligence |
| 21 | Archeon | Series A | $9.0M | 2026-10-06 | Besançon | Health care |
| 22 | SuperMush | Series A | $3.0M | 2026-10-06 | Burlington | Health care |
| 23 | RomanSive | Series A | $3.0M | 2026-10-02 | Seoul | Commerce |
| 24 | BioOra | Series A | $16.8M | 2026-10-01 | Wellington | Biotech |
| 25 | Parakeet Health | Series A | $10.0M | 2026-10-01 | San Francisco | Artificial intelligence |
| 26 | CAD Therapeutics | Series A | $4.0M | 2026-10-01 | New York | Biotech |
| 27 | R1 Therapeutics | Series A | $3.0M | 2026-09-30 | London | Biotech |
| 28 | Breye Therapeutics | Series A | $76.7M | 2026-09-29 | Hørsholm | Biotech |
| 29 | ai3Bio | Series A | $48.0M | 2026-09-29 | Pittsburgh | Biotech |
| 30 | Dyad | Series A | $10.0M | 2026-09-29 | London | Artificial intelligence |
| 31 | Purple AI | Series A | $2.4M | 2026-09-29 | Seoul | Artificial intelligence |
| 32 | Nanomerics | Series A | 2026-09-29 | Harrow | Biotech | |
| 33 | Amaani | Series A | $5.0M | 2026-09-28 | Dubai | Health care |
| 34 | p°Motion | Series A | 2026-09-25 | New York | Artificial intelligence | |
| 35 | Basalt Health | Series A | $20.0M | 2026-09-24 | Nashville | Artificial intelligence |
| 36 | Living Optics | Series A | $20.0M | 2026-09-24 | Milton Keynes | Artificial intelligence |
| 37 | ViferaXS | Series A | $13.7M | 2026-09-23 | Tübingen | Biotech |
| 38 | Fuqing Medical | Series A | $44.8M | 2026-09-22 | Hefei | Health care |
| 39 | Dialybrid | Series A | $17.2M | 2026-09-22 | Cantù | Health care |
| 40 | Bird & Be | Series A | $13.0M | 2026-09-22 | Toronto | Commerce |
| 41 | Arey | Series A | $4.2M | 2026-09-22 | Los Angeles | Commerce |
| 42 | Apollon | Series A | $3.7M | 2026-09-22 | Seoul | Artificial intelligence |
| 43 | CellsBin | Series A | 2026-09-22 | New Haven | Biotech | |
| 44 | Biolevate | Series A | $34.4M | 2026-09-21 | Paris | Artificial intelligence |
| 45 | Respiree | Series A | 2026-09-21 | Singapore | Health care | |
| 46 | Disha | Series A | $4.6M | 2026-09-19 | Gurgaon | Health care |
| 47 | Penelope Health | Series A | $100.0M | 2026-09-18 | Altrincham | Artificial intelligence |
| 48 | ImpriMed | Series A | $10.0M | 2026-09-18 | Palo Alto | Artificial intelligence |
| 49 | Altis Labs | Series A | $25.0M | 2026-09-17 | Toronto | Artificial intelligence |
| 50 | Matisse Pharmaceuticals | Series A | $16.0M | 2026-09-17 | Geleen | Biotech |
| 51 | Connexus Therapeutics | Series A | $5.0M | 2026-09-17 | Hong Kong | Biotech |
| 52 | AblePay Health | Series A | $20.0M | 2026-09-16 | Allentown | Health care |
| 53 | Ayble Health | Series A | $16.0M | 2026-09-16 | Boston | Artificial intelligence |
| 54 | Evia Bio | Series A | $5.5M | 2026-09-16 | Minneapolis | Biotech |
| 55 | Voxela, Inc. | Series A | 2026-09-16 | San Francisco | Artificial intelligence | |
| 56 | RegCell | Series A | $44.0M | 2026-09-15 | Emeryville | Biotech |
| 57 | ReEmerge | Series A | $37.0M | 2026-09-15 | New York | Health care |
| 58 | Mithrl | Series A | $20.0M | 2026-09-15 | San Francisco | Artificial intelligence |
| 59 | Nix | Series A | $10.0M | 2026-09-15 | Boston | Artificial intelligence |
| 60 | Josan-shes | Series A | $2.6M | 2026-09-15 | Tokyo | Health care |
| 61 | Sena Health | Series A | 2026-09-14 | Philadelphia | Health care | |
| 62 | UrgentIQ | Series A | $15.0M | 2026-09-11 | New York | Artificial intelligence |
| 63 | West Lake Xinchen | Series A | $14.8M | 2026-09-11 | Hangzhou | Artificial intelligence |
| 64 | Graph AI | Series A | $13.3M | 2026-09-10 | Pleasanton | Artificial intelligence |
| 65 | ANA Healthcare | Series A | $2.6M | 2026-09-10 | Marseille | Artificial intelligence |
| 66 | Elehear | Series A | $1.5M | 2026-09-10 | Seattle | Artificial intelligence |
| 67 | Solstice Oncology | Series A | $225.0M | 2026-09-09 | Boston | Biotech |
| 68 | TwoStep Therapeutics | Series A | $62.5M | 2026-09-09 | Palo Alto | Biotech |
| 69 | Tectora Therapeutics | Series A | $55.0M | 2026-09-09 | New York | Biotech |
| 70 | Caspian Therapeutics | Series A | $50.0M | 2026-09-09 | San Diego | Biotech |
| 71 | Epsilon Health | Series A | $20.0M | 2026-09-09 | San Francisco | Artificial intelligence |
| 72 | Hemp Solutions | Series A | $2.0M | 2026-09-09 | Paarl | Energy |
| 73 | N&E Innovations | Series A | $1.7M | 2026-09-09 | Singapore | Biotech |
| 74 | BrainChild Bio | Series A | $116.0M | 2026-09-08 | Seattle | Biotech |
| 75 | Deneb Medical | Series A | $17.1M | 2026-09-08 | Donostia-san Sebastián | Artificial intelligence |
| 76 | GenHealth.ai | Series A | $16.5M | 2026-09-08 | Vienna | Artificial intelligence |
| 77 | Hope Care Health | Series A | $7.0M | 2026-09-08 | Óbidos | Health care |
| 78 | Vaxdyn | Series A | $12.8M | 2026-09-07 | Sevilla | Biotech |
| 79 | Anivance AI Corporation | Series A | $6.3M | 2026-09-07 | Hsinchu | Artificial intelligence |
| 80 | Medulance | Series A | $2.5M | 2026-09-04 | New Delhi | Hardware |
| 81 | Cradlewise | Series A | $12.0M | 2026-09-03 | San Francisco | Artificial intelligence |
| 82 | SiccaNova Therapeutics | Series A | $7.9M | 2026-09-03 | Tsukuba | Biotech |
| 83 | KylinWay | Series A | 2026-09-03 | Hangzhou | Health care | |
| 84 | Typewriter Therapeutics | Series A | $56.3M | 2026-09-02 | Cambridge | Biotech |
| 85 | Norbert Health | Series A | $14.0M | 2026-09-01 | Brooklyn | Artificial intelligence |
| 86 | Amyl Therapeutics | Series A | $9.6M | 2026-09-01 | Liège | Biotech |
| 87 | EIT Pharma | Series A | $35.0M | 2026-08-31 | Kirkland | Biotech |
| 88 | Xianyan Biopharma | Series A | $21.8M | 2026-08-31 | Chengdu | Biotech |
| 89 | ABLE Labs | Series A | $8.8M | 2026-08-31 | Incheon | Biotech |
| 90 | Digicuto | Series A | $17.4M | 2026-08-28 | Marseille | Artificial intelligence |
| 91 | Selio Medical | Series A | $5.8M | 2026-08-28 | Dublin | Health care |
| 92 | Marvel Stone Healthcare | Series A | 2026-08-28 | Wuxi Shi | Biotech | |
| 93 | Hepo Biotechnology | Series A | 2026-08-28 | Shanghai | Biotech | |
| 94 | Metriport | Series A | $26.0M | 2026-08-27 | San Francisco | Artificial intelligence |
| 95 | Onos Health | Series A | $17.0M | 2026-08-26 | San Francisco | Artificial intelligence |
| 96 | Hike Medical | Series A | $22.5M | 2026-08-25 | San Francisco | Artificial intelligence |
| 97 | TECLens | Series A | $10.0M | 2026-08-25 | Stamford | Biotech |
| 98 | Anda Biopharma | Series A | 2026-08-24 | Shenzhen | Artificial intelligence | |
| 99 | SiranBio | Series A | $59.5M | 2026-08-20 | Suzhou | Biotech |
| 100 | MaxQ Medical | Series A | $20.0M | 2026-08-20 | Sunnyvale | Health care |
Table 1. The 100 most recent rounds. Source: FundingWatcher. Data as of 23 October 2026. Base: 5,293.
Largest rounds
Largest round first
100 rows
| # | Company | Round | Amount | Date | City | Sector |
|---|---|---|---|---|---|---|
| 1 | Altos Labs | Series A | $3.0B | 2021-09-06 | San Francisco | Biotech |
| 2 | Ping An Healthcare Management | Series A | $1.1B | 2018-02-03 | Shanghai | Fintech |
| 3 | Xaira Therapeutics | Series A | $1.0B | 2024-04-23 | South San Francisco | Artificial intelligence |
| 4 | Verdiva Bio | Series A | $411.0M | 2025-01-09 | London | Biotech |
| 5 | LianBio | Series A | $310.0M | 2020-10-29 | Shanghai | Biotech |
| 6 | Uniquity Bio | Series A | $300.0M | 2024-05-15 | Malvern | Biotech |
| 7 | ReNAgade Therapeutics | Series A | $300.0M | 2023-05-23 | Cambridge | Biotech |
| 8 | Mabwell Biotech | Series A | $278.5M | 2020-04-29 | Shanghai | Biotech |
| 9 | Orbital Therapeutics | Series A | $270.0M | 2023-04-26 | Cambridge | Biotech |
| 10 | NantOmics | Series A | $250.8M | 2015-06-01 | Culver City | Biotech |
| 11 | Anthos Therapeutics | Series A | $250.0M | 2019-02-27 | Cambridge | Biotech |
| 12 | Aiolos Bio | Series A | $245.0M | 2023-10-24 | San Francisco | Biotech |
| 13 | Solstice Oncology | Series A | $225.0M | 2026-09-09 | Boston | Biotech |
| 14 | BlueRock Therapeutics | Series A | $225.0M | 2016-12-12 | Toronto | Biotech |
| 15 | Dispatch Bio | Series A | $216.0M | 2025-07-23 | Philadelphia | Biotech |
| 16 | Tome Biosciences | Series A | $213.0M | 2023-12-12 | Watertown | Biotech |
| 17 | AirNexis Therapeutics | Series A | $200.0M | 2026-01-09 | Palo Alto | Biotech |
| 18 | Treeline Biosciences | Series A | $200.0M | 2025-09-03 | Watertown | Biotech |
| 19 | Tenvie Therapeutics | Series A | $200.0M | 2025-01-08 | Brisbane | Biotech |
| 20 | Callio Therapeutics | Series A | $187.0M | 2025-03-03 | Seattle | Biotech |
| 21 | Braveheart Bio | Series A | $185.0M | 2025-11-05 | San Francisco | Biotech |
| 22 | cAMPfield Therapeutics | Series A | $180.0M | 2026-05-20 | San Diego | Biotech |
| 23 | Timberlyne Therapeutics | Series A | $180.0M | 2025-01-09 | San Diego | Biotech |
| 24 | Antares Therapeutics | Series A | $177.0M | 2025-05-15 | Boston | Biotech |
| 25 | Allist Pharmaceuticals | Series A | $173.9M | 2019-05-24 | Shanghai | Biotech |
| 26 | SPH KYUAN | Series A | $173.9M | 2015-08-18 | Fengtai | Health care |
| 27 | Syremis Therapeutics | Series A | $165.0M | 2025-12-18 | Tel Aviv | Health care |
| 28 | Wego | Series A | $155.0M | 2021-10-29 | Nanshan | Health care |
| 29 | Clasp Therapeutics | Series A | $150.0M | 2024-03-20 | Cambridge | Biotech |
| 30 | Curon Biopharma | Series A | $150.0M | 2018-07-30 | Shanghai | Biotech |
| 31 | Bitterroot Bio | Series A | $145.0M | 2023-06-07 | Palo Alto | Biotech |
| 32 | Doma Biopharmaceutical | Series A | $142.1M | 2022-06-01 | Suzhou | Biotech |
| 33 | Ottimo Pharma | Series A | $140.0M | 2024-12-19 | Sandwich | Biotech |
| 34 | United Imaging Intelligence | Series A | $139.3M | 2025-06-20 | Xuhui | Health care |
| 35 | VectorY | Series A | $138.0M | 2023-11-13 | Amsterdam | Biotech |
| 36 | Serapha Bio | Series A | $138.0M | 2026-01-01 | New York | Biotech |
| 37 | EverBridge | Series A | $137.8M | 2025-03-25 | Changning | Health care |
| 38 | EasyHealth | Series A | $135.0M | 2021-11-18 | Los Angeles | Fintech |
| 39 | Reunion Neuroscience | Series A | $133.0M | 2025-09-16 | Toronto | Biotech |
| 40 | Slate Medicines | Series A | $130.0M | 2026-02-24 | Raleigh | Biotech |
| 41 | Beeline Medicines | Series A | $126.3M | 2026-06-30 | Boston | Biotech |
| 42 | Coultreon Biopharma | Series A | $125.0M | 2026-04-28 | Heverlee | Biotech |
| 43 | Ambros Therapeutics | Series A | $125.0M | 2025-12-16 | Irvine | Biotech |
| 44 | Adcytherix | Series A | $122.8M | 2025-10-16 | Marseille | Biotech |
| 45 | NGM Biopharmaceuticals | Series A | $122.0M | 2024-07-17 | South San Francisco | Biotech |
| 46 | Merida Biosciences | Series A | $121.0M | 2025-04-08 | Cambridge | Biotech |
| 47 | Solve Therapeutics | Series A | $120.0M | 2025-11-17 | Belmont | Biotech |
| 48 | Ouro Medicines | Series A | $120.0M | 2025-01-10 | San Francisco | Biotech |
| 49 | Cellular Biomedicine Group | Series A | $120.0M | 2021-09-28 | Palo Alto | Biotech |
| 50 | BrainChild Bio | Series A | $116.0M | 2026-09-08 | Seattle | Biotech |
| 51 | Myricx Bio | Series A | $115.3M | 2024-07-08 | London | Biotech |
| 52 | Axonis Therapeutics | Series A | $115.0M | 2024-10-30 | Boston | Biotech |
| 53 | Author Health | Series A | $115.0M | 2023-06-28 | Boston | Health care |
| 54 | RQ Bio | Series A | $112.5M | 2026-06-24 | London | Biotech |
| 55 | Kynexis | Series A | $112.3M | 2026-08-19 | Naarden | Biotech |
| 56 | Syncromune | Series A | $111.8M | 2024-12-20 | Fort Lauderdale | Biotech |
| 57 | Zephyr AI | Series A | $111.0M | 2024-03-13 | Fairfax Station | Artificial intelligence |
| 58 | PanTera | Series A | $110.3M | 2024-09-11 | Mol | Health care |
| 59 | Zarminali Health | Series A | $110.0M | 2026-01-21 | Chicago | Health care |
| 60 | RayThera | Series A | $110.0M | 2025-04-04 | San Diego | Biotech |
| 61 | Neogene Therapeutics | Series A | $110.0M | 2020-09-14 | Amsterdam | Biotech |
| 62 | Sidera Bio | Series A | $109.0M | 2025-12-09 | Copenhagen | Biotech |
| 63 | AavantiBio | Series A | $107.0M | 2020-10-22 | Cambridge | Biotech |
| 64 | Synnovation Therapeutics | Series A | $102.0M | 2023-12-14 | Wilmington | Biotech |
| 65 | NILO Therapeutics | Series A | $101.0M | 2025-10-08 | New York | Biotech |
| 66 | Trace Neuroscience | Series A | $101.0M | 2024-11-12 | South San Francisco | Biotech |
| 67 | Penelope Health | Series A | $100.0M | 2026-09-18 | Altrincham | Artificial intelligence |
| 68 | Stipple Bio | Series A | $100.0M | 2026-04-06 | Cambridge | Biotech |
| 69 | Addition Therapeutics | Series A | $100.0M | 2025-12-17 | South San Francisco | Biotech |
| 70 | Nudge | Series A | $100.0M | 2025-07-22 | San Francisco | Biotech |
| 71 | C Ray Therapeutics | Series A | $100.0M | 2024-11-16 | Chengdu | Health care |
| 72 | Lumeris | Series A | $100.0M | 2024-04-10 | St Louis | Health care |
| 73 | OnCusp Therapeutics | Series A | $100.0M | 2024-01-04 | New York | Biotech |
| 74 | Inceptive | Series A | $100.0M | 2023-09-07 | Palo Alto | Biotech |
| 75 | Paratus Sciences | Series A | $100.0M | 2023-02-27 | New York | Biotech |
| 76 | Allied Health Clinics | Series A | $100.0M | 2022-07-04 | Cape Town | Health care |
| 77 | Reistone Biopharma | Series A | $100.0M | 2022-05-09 | Pudong | Biotech |
| 78 | Tichuang Biotechnology | Series A | $100.0M | 2022-03-14 | Guangzhou | Biotech |
| 79 | Rectify Pharmaceuticals | Series A | $100.0M | 2021-10-14 | Cambridge | Biotech |
| 80 | Dyno Therapeutics | Series A | $100.0M | 2021-05-06 | Cambridge | Artificial intelligence |
| 81 | Joyn Bio | Series A | $100.0M | 2017-09-14 | Boston | Biotech |
| 82 | Emergence Therapeutics | Series A | $98.1M | 2021-12-07 | Duisburg | Biotech |
| 83 | NanoPhoria | Series A | $97.8M | 2025-10-06 | Milan | Biotech |
| 84 | Cajal Neuroscience | Series A | $96.0M | 2022-11-29 | Seattle | Biotech |
| 85 | Trogenix | Series A | $94.1M | 2025-10-06 | Edinburgh | Biotech |
| 86 | Firefly Bio | Series A | $94.0M | 2024-02-15 | San Francisco | Biotech |
| 87 | Estuary Biotherapeutics | Series A | $93.0M | 2026-10-16 | San Francisco | Biotech |
| 88 | Memento Medicines | Series A | $93.0M | 2026-06-18 | Chester | Biotech |
| 89 | Kivu Bioscience | Series A | $92.0M | 2024-10-28 | San Mateo | Biotech |
| 90 | Bambusa Therapeutics | Series A | $90.0M | 2025-11-17 | Boston | Biotech |
| 91 | AtomVie Global Radiopharma | Series A | $90.0M | 2023-06-01 | Hamilton | Health care |
| 92 | Nested Therapeutics | Series A | $90.0M | 2022-10-06 | Cambridge | Biotech |
| 93 | Turing Pharmaceuticals | Series A | $90.0M | 2015-08-10 | New York | Biotech |
| 94 | Clade Therapeutics | Series A | $87.0M | 2021-11-03 | Cambridge | Biotech |
| 95 | MoleculeMind | Series A | $86.0M | 2026-06-17 | Haidian | Artificial intelligence |
| 96 | Rhygaze | Series A | $86.0M | 2025-01-10 | Basel | Biotech |
| 97 | Stylus Medicine | Series A | $85.0M | 2025-05-12 | Cambridge | Biotech |
| 98 | Rampart Bioscience | Series A | $85.0M | 2023-10-24 | La Jolla | Biotech |
| 99 | Epirium Bio | Series A | $85.0M | 2019-12-18 | San Diego | Biotech |
| 100 | Averna Therapeutics | Series A | $85.0M | 2024-06-25 | Boston | Biotech |
Table 2. The 100 largest rounds. Source: FundingWatcher. Data as of 23 October 2026. Base: 5,293.
By month
| Month | Companies |
|---|---|
| 2024-11 | 50 |
| 2024-12 | 54 |
| 2025-01 | 68 |
| 2025-02 | 36 |
| 2025-03 | 44 |
| 2025-04 | 49 |
| 2025-05 | 44 |
| 2025-06 | 54 |
| 2025-07 | 48 |
| 2025-08 | 57 |
| 2025-09 | 70 |
| 2025-10 | 61 |
| 2025-11 | 57 |
| 2025-12 | 73 |
| 2026-01 | 73 |
| 2026-02 | 49 |
| 2026-03 | 53 |
| 2026-04 | 43 |
| 2026-05 | 40 |
| 2026-06 | 66 |
| 2026-07 | 44 |
| 2026-08 | 44 |
| 2026-09 | 60 |
| 2026-10 | 26 |
Table 3. Health care startups that raised Series A by month of the round. Source: FundingWatcher. Data as of 23 October 2026. Base: 5,293.
Country
| Country | Companies |
|---|---|
| United States | 2,256 |
| China | 1,173 |
| United Kingdom | 213 |
| South Korea | 201 |
| India | 144 |
| France | 132 |
| Germany | 129 |
| Canada | 105 |
| Japan | 95 |
| Switzerland | 89 |
| Israel | 87 |
| Australia | 49 |
| Singapore | 47 |
| The Netherlands | 46 |
| Spain | 44 |
Table 4. Health care startups that raised Series A by country. Source: FundingWatcher. Data as of 23 October 2026. Base: 5,293.
City
| City | Companies |
|---|---|
| New York | 229 |
| San Francisco | 215 |
| Beijing | 163 |
| Shanghai | 149 |
| Shenzhen | 110 |
| Cambridge | 105 |
| London | 99 |
| Hangzhou | 99 |
| Boston | 97 |
| Seoul | 88 |
| Suzhou | 72 |
| San Diego | 69 |
| Los Angeles | 58 |
| Paris | 57 |
| Palo Alto | 50 |
Table 5. Health care startups that raised Series A by city. Source: FundingWatcher. Data as of 23 October 2026. Base: 5,293.
Sector
| Sector | Companies |
|---|---|
| Health care | 5,293 |
| Biotech | 1,918 |
| Software | 1,134 |
| Artificial intelligence | 518 |
| Hardware | 324 |
| Commerce | 199 |
| Fintech | 188 |
| Education | 84 |
| Energy | 27 |
| Cybersecurity | 18 |
Table 6. Health care startups that raised Series A by sector. Source: FundingWatcher. Data as of 23 October 2026. Base: 5,293.
Health care at other stages
Other sectors that raised Series A
software startups that raised Series A13,476
AI startups that raised Series A4,099
fintech startups that raised Series A3,591
commerce startups that raised Series A3,642
hardware startups that raised Series A4,443
biotech startups that raised Series A2,368
education startups that raised Series A1,269
cybersecurity startups that raised Series A1,155
energy startups that raised Series A1,029
Cite: FundingWatcher, 5,293 health care companies whose most recent round is Series A, 23 October 2026. https://fundingwatcher.com/startups/health-care/series-a/